Evidence map›Paper›PMID 33768125›Full record

ArticleMolecular therapy. Methods & clinical development2021

NaCl and KCl mediate log increase in AAV vector particles and infectious titers in a specific/timely manner with the HSV platform.

Chenghui Yu, Prasad D Trivedi, Payel Chaudhuri, Radhika Bhake, Evan J Johnson, Tina Caton, Mark Potter, Barry J Byrne, Nathalie Clément

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Repeated harvest enables efficient production of VSV-GP.Frontiers in bioengineering and biotechnology · 2024
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Chenghui YuDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Prasad D TrivediDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Payel ChaudhuriDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Radhika BhakeDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Evan J JohnsonDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Tina CatonDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Mark PotterDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Barry J ByrneDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
Nathalie ClémentDepartment of Pediatrics, Powell Gene Therapy Center, University of Florida, 1200 Newell Drive, Academic Research Building, RG-187, Gainesville, FL 32610, USA.
University of Florida · USFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing demand for adeno-associated virus (AAV) vectors, a result from the surging interest for their potential to cure human genetic diseases by gene transfer, tumbled on low-performing production systems. Innovative improvements to increase both yield and quality of the vector produced have become a priority undertaking in the field. In a previous study, we showed that adding a specific concentration of sodium chloride (NaCl) to the production medium resulted in a dramatic increase of AAV vector particle and infectious titers when using the herpes simplex virus (HSV) production system, both in adherent or suspension platforms. In this work, we studied additional salts and their impact on AAV vector production. We found that potassium chloride (KCl), or a combination of KCl and NaCl, resulted in the highest increase in AAV vector production. We determined that the salt-mediated effect was the most impactful when the salt was present between 8 and approximately 16 h post-infection, with the highest rate increase occurring within the first 24 h of the production cycle. We showed that the AAV vector yield increase did not result from an increase in cell growth, size, or viability. Furthermore, we demonstrated that the impact on AAV vector production was specifically mediated by NaCl and KCl independently of their impact on the osmolality of the production media. Our findings convincingly showed that NaCl and KCl were uniquely efficacious to promote up to a 10-fold increase in the production of highly infectious AAV vectors when produced in the presence of HSV. We think that this study will provide unique and important new insights in AAV biology toward the establishment of more successful production protocols.

Indexed as

AAVAdeno-associated vectorsGene TherapyHSV-1Production

Identifiers

PMID33768125
PMCPMC7960503
OpenAlexW3132813048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.